SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 83,700
-2,800 (-3.24%)
Aug 21, 2026, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.55 trillion as of August 21, 2026. Its market cap has decreased by -13.71% in one year.
Market Cap
6.55T
Enterprise Value
6.22T
Revenue
861.34B
Ranking
n/a
PE Ratio
16.35
Stock Price
83,700.00
ChartMarket Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.55T, a decrease of -34.09%. That is a compound annual growth rate of -6.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 6.55T | -32.83% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| HLB Co., Ltd. | 5.14T |
| ABL Bio | 4.21T |
| Peptron | 4.16T |
| LigaChem Biosciences | 3.68T |
| SK bioscience | 2.86T |
| Voronoi | 2.74T |